RGNX
Regenxbio Inc
7.80$
+4.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.8% | 70.1% | 54.2% | 65.6% | 51.2% | 29.8% | 3.9% | 42.7% | 207.9% | 19.5% | 173.2% | 1.0% | 45.8% | |
| 57.2% | 29.9% | 45.8% | 34.4% | 48.8% | 70.2% | 96.1% | 57.3% | -107.9% | 80.5% | -73.2% | 99.0% | 54.2% | |
| 201.2% | 231.2% | 324.3% | 201.0% | 224.9% | 237.5% | 59.6% | 260.3% | 188.7% | 196.5% | 896.9% | 51.9% | 131.3% | |
| 79.8% | 85.9% | 117.1% | 84.6% | 80.3% | 94.5% | 22.9% | 93.1% | 68.1% | 73.8% | 333.3% | 20.0% | 49.0% | |
| 281.8% | 317.6% | 441.2% | 285.7% | 305.4% | 312.4% | 82.5% | 353.6% | 68.3% | 270.4% | 1,230.7% | 71.9% | 148.3% | |
| -224.7% | -287.7% | -395.4% | -251.3% | -256.6% | -242.1% | 13.6% | -296.3% | -176.3% | -190.0% | -1,304.0% | 27.1% | -94.1% | |
| 5.6% | 6.1% | 12.6% | 2.0% | 3.4% | 44.4% | 9.6% | 51.5% | 44.3% | 40.5% | 136.2% | 7.2% | 24.0% | |
| -214.0% | -283.8% | -405.4% | -237.7% | -246.3% | -241.3% | 6.8% | -331.8% | -208.3% | -221.3% | -1,408.6% | 21.0% | -112.6% | |
| -9.5% | -0.7% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| -214.0% | -283.1% | -405.4% | -237.7% | -246.3% | -241.3% | 6.8% | -331.8% | -208.3% | -221.3% | -1,408.6% | 21.0% | -112.6% | |
| -193.2% | -258.2% | -366.0% | -217.5% | -226.5% | -177.9% | 20.9% | -262.1% | -151.0% | -168.1% | -1,212.0% | 31.7% | -79.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.